T, H., H, J., T, B., KV, H., BV, E., R, B., . . . L, E. (2022). A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma. Annals of hematology, 101(5), 1077. https://doi.org/10.1007/s00277-022-04789-9
Chicago Style (17th ed.) CitationT, Husby, Johansen H, Bogsrud T, Hustad KV, Evensen BV, Boellard R, Giskeødegård GF, Fagerli UM, and Eikenes L. "A Comparison of FDG PET/MR and PET/CT for Staging, Response Assessment, and Prognostic Imaging Biomarkers in Lymphoma." Annals of Hematology 101, no. 5 (2022): 1077. https://doi.org/10.1007/s00277-022-04789-9.
MLA (9th ed.) CitationT, Husby, et al. "A Comparison of FDG PET/MR and PET/CT for Staging, Response Assessment, and Prognostic Imaging Biomarkers in Lymphoma." Annals of Hematology, vol. 101, no. 5, 2022, p. 1077, https://doi.org/10.1007/s00277-022-04789-9.